-
1
-
-
0033128905
-
Inhibition of CFU-E colony formation in uremic patients with inflammatory disease: Role of IFN-γ and TNF-α
-
Allen DA, Breen C, Yaqoob MM, Macdougall IC. Inhibition of CFU-E colony formation in uremic patients with inflammatory disease: role of IFN-γ and TNF-α. J Invest Med. 1999; 7: 204-211.
-
(1999)
J Invest Med
, vol.7
, pp. 204-211
-
-
Allen, D.A.1
Breen, C.2
Yaqoob, M.M.3
Macdougall, I.C.4
-
2
-
-
10744232171
-
Changes in viremia and circulating interferon-α during hemodialysis in hepatitis C virus-positive patients: Only coincidental phenomena?
-
Badalamenti S, Catania A, Lunghi G, Covini G, Bredi E, Brancaccio D, Salvadori M, Como G, Ponticelli C, Graziani G. Changes in viremia and circulating interferon-α during hemodialysis in hepatitis C virus-positive patients: only coincidental phenomena? Am J Kidney Dis. 2003; 42: 143-150.
-
(2003)
Am J Kidney Dis
, vol.42
, pp. 143-150
-
-
Badalamenti, S.1
Catania, A.2
Lunghi, G.3
Covini, G.4
Bredi, E.5
Brancaccio, D.6
Salvadori, M.7
Como, G.8
Ponticelli, C.9
Graziani, G.10
-
3
-
-
13944250319
-
Natural History Study Group. Erythropoietic response to anemia in chronic hepatitis C patients receiving combination pegylated interferon/ ribavirin
-
Balan V, Schwartz D, Wu GY, Muir AJ, Ghalib R, Jackson J, Keefe EB, Rossaro L, Burnett A, Goon BL, Bowers PJ, Leitz GJ. HCV Natural History Study Group. Erythropoietic response to anemia in chronic hepatitis C patients receiving combination pegylated interferon/ ribavirin. Am J Gastroenterol. 2005; 100: 299-307.
-
(2005)
Am J Gastroenterol
, vol.100
, pp. 299-307
-
-
Balan, V.1
Schwartz, D.2
Wu, G.Y.3
Muir, A.J.4
Ghalib, R.5
Jackson, J.6
Keefe, E.B.7
Rossaro, L.8
Burnett, A.9
Goon, B.L.10
Bowers, P.J.11
Leitz GJ, H.C.V.12
-
4
-
-
16644391871
-
Spanish Society of Nephrology (Guidelines on hemodialysis-associated viral infections)
-
Barril G, Gonzalez Parra E, Alcazar R, Arenas D, Campistol JM, Caramelo C, Carrasco M, Carreno V, Espinosa M, Garcia Valdecasas J, Gorriz JL, Lopez MD, Martin L, Ruiz P, Teruel JL. Spanish Society of Nephrology (Guidelines on hemodialysis-associated viral infections). Nefrologia. 2004; 24 (Suppl 2): 43-66.
-
(2004)
Nefrologia
, vol.24
, Issue.SUPPL. 2
, pp. 43-66
-
-
Barril, G.1
Gonzalez Parra, E.2
Alcazar, R.3
Arenas, D.4
Campistol, J.M.5
Caramelo, C.6
Carrasco, M.7
Carreno, V.8
Espinosa, M.9
Garcia Valdecasas, J.10
Gorriz, J.L.11
Lopez, M.D.12
Martin, L.13
Ruiz, P.14
Teruel, J.L.15
-
5
-
-
4344625164
-
2b in naive patients with chronic hepatitis C: A randomized, controlled study
-
2b in naive patients with chronic hepatitis C: a randomized, controlled study. Antivir Ther. 2004; 9: 491-497.
-
(2004)
Antivir Ther
, vol.9
, pp. 491-497
-
-
Bruno, R.1
Sacchi, P.2
Ciappina, V.3
Zochetti, C.4
Patruno, S.5
Maiocchi, L.6
Filice, G.7
-
6
-
-
18444405565
-
Pharmacokinetics of pegylated interferons: What is misleading?
-
Caliceti P. Pharmacokinetics of pegylated interferons: what is misleading? Dig Liver Dis. 2004; 36 (Suppl 3): S334-339.
-
(2004)
Dig Liver Dis
, vol.36
, Issue.SUPPL. 3
-
-
Caliceti, P.1
-
7
-
-
0037530608
-
Increased expression of erythropoiesis inhibiting cytokines (IFN-μ, TNF-α, IL-10 and IL-13) by T cells inpatients exhibiting a poor response to erythropoietin therapy
-
Cooper AC, Mikhail A, Lethbridge MW, Kemeny DM, Macdougall IC. Increased expression of erythropoiesis inhibiting cytokines (IFN-μ, TNF-α, IL-10 and IL-13) by T cells inpatients exhibiting a poor response to erythropoietin therapy. J Am Soc Nephrol. 2003; 14: 1776-1784.
-
(2003)
J Am Soc Nephrol
, vol.14
, pp. 1776-1784
-
-
Cooper, A.C.1
Mikhail, A.2
Lethbridge, M.W.3
Kemeny, D.M.4
Macdougall, I.C.5
-
8
-
-
0242437747
-
Once-weekly epoetin-α improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus-infected patients receiving ribavirin plus interferon-α
-
Dieterich DT, Wasserman R, Brau N, Hassanein TI, Bini EJ, Bowers PJ, Sulkowski MS. Once-weekly epoetin-α improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus-infected patients receiving ribavirin plus interferon-α. Am J Gastroenterol. 2003; 98: 2491-2499.
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 2491-2499
-
-
Dieterich, D.T.1
Wasserman, R.2
Brau, N.3
Hassanein, T.I.4
Bini, E.J.5
Bowers, P.J.6
Sulkowski, M.S.7
-
9
-
-
12144288521
-
Marked reduction in the prevalence of hepatitis C virus infection in hemodialysis patients; causes and consequences
-
Espinosa M, Martin-Malo A, Ojeda R, Santamaria R, Soriano S, Aguera M, Aljama P. Marked reduction in the prevalence of hepatitis C virus infection in hemodialysis patients; causes and consequences. Am J Kidney Dis. 2004; 43: 685-689.
-
(2004)
Am J Kidney Dis
, vol.43
, pp. 685-689
-
-
Espinosa, M.1
Martin-Malo, A.2
Ojeda, R.3
Santamaria, R.4
Soriano, S.5
Aguera, M.6
Aljama, P.7
-
10
-
-
2442642562
-
Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS
-
Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, Rayner HC, Greenwood RN, Akiba T, Young EW. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2004; 65: 2335-2342.
-
(2004)
Kidney Int
, vol.65
, pp. 2335-2342
-
-
Fissell, R.B.1
Bragg-Gresham, J.L.2
Woods, J.D.3
Jadoul, M.4
Gillespie, B.5
Hedderwick, S.A.6
Rayner, H.C.7
Greenwood, R.N.8
Akiba, T.9
Young, E.W.10
-
11
-
-
18544362355
-
2b in patients with chronic renal dysfunction
-
2b in patients with chronic renal dysfunction. J Clin Pharmacol. 2002; 42: 1109-1115.
-
(2002)
J Clin Pharmacol
, vol.42
, pp. 1109-1115
-
-
Gupta, S.K.1
Pittenger, A.L.2
Swan, S.K.3
Marbury, T.C.4
Tobillo, E.5
Batra, V.6
Sack, M.7
Glue, P.8
Jacobs, S.9
Affrime, M.10
-
14
-
-
0035934568
-
2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
-
2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet, 2001; 358: 958-965.
-
(2001)
Lancet
, vol.358
, pp. 958-965
-
-
Manns, M.P.1
McHutchison, J.G.2
Gordon, S.C.3
Rustgi, V.K.4
Shiffman, M.5
Reindollar, R.6
Goodman, Z.D.7
Koury, K.8
Ling, M.9
Albrecht, J.K.10
-
15
-
-
0029862721
-
Inhibition of human erythroid colony-forming units by interferons α and β: Differing mechanisms despite shared receptor
-
Means RT, Krantz SB. Inhibition of human erythroid colony-forming units by interferons α and β: differing mechanisms despite shared receptor. Exp Hematol. 1996; 24: 204-208.
-
(1996)
Exp Hematol
, vol.24
, pp. 204-208
-
-
Means, R.T.1
Krantz, S.B.2
-
18
-
-
0038119080
-
Interferon monotherapy for dialysis patients with chronic hepatitis C: An analysis of the literature on efficacy and safety
-
Russo MW, Goldsweig CD, Jacobson IM, Brown RS Jr. Interferon monotherapy for dialysis patients with chronic hepatitis C: an analysis of the literature on efficacy and safety. Am J Gastroenterol. 2003; 98: 1610-1615.
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 1610-1615
-
-
Russo, M.W.1
Goldsweig, C.D.2
Jacobson, I.M.3
Brown Jr, R.S.4
-
19
-
-
0028867534
-
Interferon-α-induced apoptosis in human erythroid progenitors
-
Tarumi T, Sawada K, Sato N, Kobayashi S, Takano H, Yasukouchi T, Takashashi T, Sekiguchi S, Koike T. Interferon-α-induced apoptosis in human erythroid progenitors. Exp Hematol. 1995; 23: 1310-1318.
-
(1995)
Exp Hematol
, vol.23
, pp. 1310-1318
-
-
Tarumi, T.1
Sawada, K.2
Sato, N.3
Kobayashi, S.4
Takano, H.5
Yasukouchi, T.6
Takashashi, T.7
Sekiguchi, S.8
Koike, T.9
-
20
-
-
0034619946
-
-
2a in patients with chronic hepatitis C. N Engl J Med. 2000; 343: 1666-1672.
-
2a in patients with chronic hepatitis C. N Engl J Med. 2000; 343: 1666-1672.
-
-
-
-
21
-
-
0041317671
-
-
Zeuzem S, Welsch C, Herrmann E. Pharmacokinetics of peginterferons. Semin Liver Dis. 2003; 23 (Suppl) 1: 23-28.
-
Zeuzem S, Welsch C, Herrmann E. Pharmacokinetics of peginterferons. Semin Liver Dis. 2003; 23 (Suppl) 1: 23-28.
-
-
-
|